The 3 year strategic plan set in 2022, was to double revenue by FY2025 through acquisitions and organic growth.
At the time money was cheap with low cost of funding (interest rates).
They went on an acquisition spree mainly through 2021 - 2023 and when cost of debt rose they’ve been hit particularly hard due to over-leverage.
Finance cost taking up approx $7m per annum from EBITDA. They have stopped their acquisition spree so we should start to see debt come down going forward provided they can maintain their strong growth
- Forums
- ASX - By Stock
- AHX
- Debt levels
Debt levels, page-3
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AHX (ASX) to my watchlist
(20min delay)
|
|||||
Last
50.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $92.17M |
Open | High | Low | Value | Volume |
50.5¢ | 50.5¢ | 50.5¢ | $15.46K | 30.61K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 11000 | 50.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
52.0¢ | 750 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 11000 | 0.500 |
2 | 52040 | 0.490 |
2 | 63750 | 0.485 |
2 | 4000 | 0.480 |
1 | 20000 | 0.470 |
Price($) | Vol. | No. |
---|---|---|
0.520 | 750 | 1 |
0.530 | 20000 | 1 |
0.540 | 8560 | 1 |
0.545 | 13224 | 1 |
0.550 | 44154 | 7 |
Last trade - 11.47am 12/11/2024 (20 minute delay) ? |
Featured News
AHX (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online